University of Oxford
Industry
- Biotechnology
- Academic and Research Institutions
Other Names/Subsidiaries
- Isis Innovation
- Oxford University Innovation
Latest on University of Oxford
GSK is extending its relationship with the University of Oxford to research the potential of cancer prevention through vaccine-like immunotherapies. The GSK-Oxford Cancer Immuno-Prevention Programme w
India could step up to the plate with a vaccine to prevent mpox, classified as a public health emergency of international concern (PHEIC) once again post 2022 by the World Health Organization (WHO) af
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Boehringer Ingelheim Acquires Nerio The
Investor interest in biopharmaceutical opportunities is slowly but surely improving in 2024, including both private investors and public-sector funders of drug development infrastructure. In mid-month